These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 38192633)

  • 1. TME-Related Biomimetic Strategies Against Cancer.
    Peng C; Xu Y; Wu J; Wu D; Zhou L; Xia X
    Int J Nanomedicine; 2024; 19():109-135. PubMed ID: 38192633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
    Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
    J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
    Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
    Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?
    Tajaldini M; Saeedi M; Amiriani T; Amiriani AH; Sedighi S; Mohammad Zadeh F; Dehghan M; Jahanshahi M; Zanjan Ghandian M; Khalili P; Poorkhani AH; Alizadeh AM; Khori V
    Eur J Pharmacol; 2022 Aug; 928():175087. PubMed ID: 35679891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic Nanoplatform for Dual-Targeted Clearance of Activated and Senescent Cancer-Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer.
    Jian C; Wu T; Wang L; Gao C; Fu Z; Zhang Q; Shi C
    Small; 2024 Jun; 20(25):e2309279. PubMed ID: 38214439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
    Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
    Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
    Jia M; Zhang D; Zhang C; Li C
    J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy.
    Khan GJ; Sun L; Khan S; Yuan S; Nongyue H
    Curr Drug Targets; 2018; 19(13):1573-1588. PubMed ID: 29468965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts in neoadjuvant setting for solid cancers.
    Gu Y; Chen Q; Yin H; Zeng M; Gao S; Wang X
    Crit Rev Oncol Hematol; 2024 Jan; 193():104226. PubMed ID: 38056580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
    Li M; Zhang F; Su Y; Zhou J; Wang W
    Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrotic therapy to normalize the tumor microenvironment.
    Hauge A; Rofstad EK
    J Transl Med; 2020 May; 18(1):207. PubMed ID: 32434573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment.
    Minini M; Fouassier L
    Curr Oncol; 2023 Apr; 30(4):4185-4196. PubMed ID: 37185432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells.
    Gao D; Fang L; Liu C; Yang M; Yu X; Wang L; Zhang W; Sun C; Zhuang J
    Biomed Pharmacother; 2023 Nov; 167():115622. PubMed ID: 37783155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment.
    Berger Fridman I; Kostas J; Gregus M; Ray S; Sullivan MR; Ivanov AR; Cohen S; Konry T
    Acta Biomater; 2021 Sep; 132():473-488. PubMed ID: 34153511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.